Ads
related to: neuroendocrine tumours life expectancy- Identifying Patients
Discover Patient Identification &
IHC Info. Will You Take Action?
- Official Physician Site
Visit Site For A Treatment
Option For Metastatic Solid Tumors.
- Dosing & Administration
Healthcare Professionals: See How
Your Patients May Receive Treatment
- Access Data & Results
View Data To See If A Treatment For
Metastatic Solid Tumors May Help.
- Approval Info For HCPs
Explore Eligibility Criteria For A
Therapy For Metastatic Solid Tumors
- Request A Contact
Complete A Brief Form To Receive
Updates For A Treatment Option.
- Identifying Patients
everydayhealth.com has been visited by 10K+ users in the past month
Search results
Results From The WOW.Com Content Network
Neuroendocrine tumours express somatostatin receptors providing a unique target for imaging. Octreotide is a synthetic modification of somatostatin with a longer half-life.
Neuroendocrine carcinoma of the cervix is best defined separately:Neuroendocrine: Of, relating to, or involving the interaction between the nervous system and the hormones of the endocrine glands. Carcinoma: An invasive malignant tumor derived from epithelial tissue that tends to metastasize to other areas of the body.
Merkel cell carcinoma (MCC) is a rare and aggressive skin cancer occurring in about three people per million members of the population. [1] It is also known as cutaneous APUDoma, primary neuroendocrine carcinoma of the skin, primary small cell carcinoma of the skin, and trabecular carcinoma of the skin. [2]
A carcinoid (also carcinoid tumor) is a slow-growing [1] type of neuroendocrine tumor originating in the cells of the neuroendocrine system. In some cases, metastasis may occur. Carcinoid tumors of the midgut ( jejunum , ileum , appendix , and cecum ) are associated with carcinoid syndrome .
Gastrinoma is the second most common functional pancreatic neuroendocrine tumor (pNET), with a yearly incidence of approximately 0.5 to 21.5 cases per a million of people worldwide. [5] Gastrinomas are located predominantly in the duodenum (70%) and pancreas (25%). [ 20 ]
A small intestine neuroendocrine tumor is a carcinoid in the distal small intestine or the proximal large intestine. It is a relatively rare cancer and is diagnosed in approximately 1/100000 people every year. In recent decades the incidence has increased. [1] The prognosis is comparatively good with a median survival of more than 8 years. [2]